Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus , Is a New Inhibitor of Hepatitis C Virus RNA Replication
- 15 May 2019
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 93 (10)
Abstract
Tens of millions of people are infected with hepatitis C virus (HCV) worldwide. Recently marketed direct-acting antivirals (DAAs) targeting HCV proteins have enhanced the efficacy of treatment. However, due to its high cost, this new therapy is not accessible to the vast majority of infected patients. Furthermore, treatment failures have also been reported due to the appearance of viral resistance. Here, we report on the identification of a new HCV inhibitor, dehydrojuncusol, that targets HCV NS5A and is able to inhibit RNA replication of replicons harboring resistance mutations to anti-NS5A DAAs used in current therapy. Dehydrojuncusol is a natural compound isolated from Juncus maritimus , a halophilic plant species that is very common in coastlines worldwide. This molecule might serve as a lead for the development of a new therapy that is more accessible to hepatitis C patients in the future.Keywords
All Related Versions
Funding Information
- Région Nord Pas de Calais (convention 12000080)
- European Commission (ERC-STG INTRACELLTB grant 260901)
- Agence Nationale de la Recherche (ANR-10-EQPX-04-01)
- Fonds européen de développement régional (12001407 (D-AL) Equipex Imaginex BioMed)
- Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS-18208)
This publication has 51 references indexed in Scilit:
- Epidemiology and natural history of HCV infectionNature Reviews Gastroenterology & Hepatology, 2013
- Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture systemProceedings of the National Academy of Sciences, 2012
- Hepatitis C Virus and Natural Compounds: A New Antiviral Approach?Viruses, 2012
- Distinct Functions of NS5A in Hepatitis C Virus RNA Replication Uncovered by Studies with the NS5A Inhibitor BMS-790052Journal of Virology, 2011
- The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entryHepatology, 2010
- Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo CorrelationsHepatology, 2010
- PSI-7851, a Pronucleotide of β- d -2′-Deoxy-2′-Fluoro-2′- C -Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus ReplicationAntimicrobial Agents and Chemotherapy, 2010
- Identification of GBF1 as a Cellular Factor Required for Hepatitis C Virus RNA ReplicationJournal of Virology, 2010
- Viral hepatitis and liver cancer: the case of hepatitis COncogene, 2006
- TaqMan amplification system with an internal positive control for HCV RNA quantitationJournal of Clinical Virology, 2004